Mercury Laboratories Ltd. | Small-cap | Healthcare
₹860.00
3.36%
| Mercury Laboratories Stock Comparison:
Mercury Laboratories vs Sun PharmaceuticalMercury Laboratories vs Divi's LaboratoriesMercury Laboratories vs Sun Pharma AdvancedMercury Laboratories vs Aarti DrugsMercury Laboratories vs Sequent ScientificMercury Laboratories vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 206.6M
Gross Profit 126.1M 61.02%
Operating Income 13.9M 6.75%
Net Income 11.1M 5.37%

Balance Sheet Metrics

Total Assets 742.4M
Total Liabilities 206.7M
Shareholders Equity 535.7M
Debt to Equity 0.39

Cash Flow Metrics

Revenue & Profitability Trend

Mercury Laboratories Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i751.0M755.6M753.3M579.2M686.0M
Cost of Goods Sold i289.2M305.4M306.1M237.6M313.8M
Gross Profit i461.9M450.2M447.3M341.6M372.3M
Gross Margin % i61.5%59.6%59.4%59.0%54.3%
Operating Expenses
Research & Development i-245.0K85.0K241.0K26.0K
Selling, General & Administrative i-61.2M62.2M37.0M48.8M
Other Operating Expenses i223.3M138.3M151.3M105.9M108.3M
Total Operating Expenses i223.3M199.8M213.6M143.2M157.1M
Operating Income i41.4M76.6M66.0M47.8M92.2M
Operating Margin % i5.5%10.1%8.8%8.2%13.4%
Non-Operating Items
Interest Income i-1.2M1.2M884.0K575.0K
Interest Expense i5.5M646.0K570.0K1.7M2.5M
Other Non-Operating Income-----
Pre-tax Income i46.6M69.2M74.4M50.3M79.1M
Income Tax i15.2M12.7M18.7M14.7M25.7M
Effective Tax Rate % i32.5%18.3%25.1%29.2%32.5%
Net Income i31.4M56.5M55.8M35.6M53.4M
Net Margin % i4.2%7.5%7.4%6.1%7.8%
Key Metrics
EBITDA i80.9M111.8M105.0M77.2M116.3M
EPS (Basic) i-₹47.12₹46.49₹29.68₹44.48
EPS (Diluted) i-₹47.12₹46.49₹29.68₹44.48
Basic Shares Outstanding i-1200000120000012000001200000
Diluted Shares Outstanding i-1200000120000012000001200000

Income Statement Trend

Mercury Laboratories Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i3.3M32.9M37.1M41.1M30.3M
Short-term Investments i20.8M48.0M31.5M21.2M11.5M
Accounts Receivable i257.4M218.5M213.7M167.4M225.4M
Inventory i72.1M62.1M69.0M67.8M51.6M
Other Current Assets47.2M33.4M55.6M42.5M47.5M
Total Current Assets i400.8M398.4M394.6M352.2M378.0M
Non-Current Assets
Property, Plant & Equipment i246.2M76.5M73.7M70.6M70.9M
Goodwill i263.0K254.0K408.0K562.0K838.0K
Intangible Assets i263.0K254.0K408.0K562.0K838.0K
Long-term Investments-----
Other Non-Current Assets1.9M2.7M14.7M13.9M12.1M
Total Non-Current Assets i341.6M281.2M247.1M272.1M275.7M
Total Assets i742.4M679.6M641.6M624.3M653.7M
Liabilities
Current Liabilities
Accounts Payable i98.3M51.8M63.8M68.7M117.8M
Short-term Debt i16.7M26.4M33.7M30.8M8.6M
Current Portion of Long-term Debt-----
Other Current Liabilities4.0M2.9M2.6M11.3M18.6M
Total Current Liabilities i150.8M129.4M141.8M157.5M188.3M
Non-Current Liabilities
Long-term Debt i37.8M29.2M24.7M29.0M62.4M
Deferred Tax Liabilities i14.3M12.6M18.9M22.3M21.3M
Other Non-Current Liabilities--2.0K-2.0K1.0K-1.0K
Total Non-Current Liabilities i55.9M41.8M43.6M63.8M96.4M
Total Liabilities i206.7M171.2M185.3M221.2M284.8M
Equity
Common Stock i12.0M12.0M12.0M12.0M12.0M
Retained Earnings i-59.3M42.0M25.4M29.2M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i535.7M508.4M456.3M403.1M368.9M
Key Metrics
Total Debt i54.5M55.5M58.3M59.9M71.0M
Working Capital i250.0M268.9M252.8M194.7M189.6M

Balance Sheet Composition

Mercury Laboratories Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i46.6M69.2M74.4M50.3M79.1M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-64.7M5.6M-62.0M38.5M-43.3M
Operating Cash Flow i-12.6M78.6M16.1M93.3M42.2M
Investing Activities
Capital Expenditures i-90.4M-62.7M-10.6M-18.9M-46.2M
Acquisitions i-----
Investment Purchases i--000
Investment Sales i--000
Investing Cash Flow i-90.4M-62.7M-10.6M-18.9M-46.2M
Financing Activities
Share Repurchases i-----
Dividends Paid i-4.2M-4.2M-4.2M-2.4M-4.2M
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i-19.2M-6.9M-2.1M-5.7M-5.1M
Free Cash Flow i-50.4M19.5M14.0M32.7M35.9M
Net Change in Cash i-122.3M9.0M3.4M68.7M-9.0M

Cash Flow Trend

Mercury Laboratories Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 31.75
Price to Book 1.86
Price to Sales 1.30

Profitability Ratios

Profit Margin 4.93%
Operating Margin 8.34%
Return on Equity 5.87%
Return on Assets 4.24%

Financial Health

Current Ratio 2.66
Debt to Equity 10.18
Beta 0.63

Per Share Data

EPS (TTM) ₹26.21
Book Value per Share ₹446.41
Revenue per Share ₹637.70

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
mercurylab998.5M31.751.865.87%4.93%10.18
Sun Pharmaceutical 3.9T37.885.4515.08%19.29%3.26
Divi's Laboratories 1.6T70.4210.8814.64%23.89%0.03
Sun Pharma Advanced 45.5B-13.34-21.04157.88%-53.22%-1.24
Aarti Drugs 44.4B23.593.2512.28%7.80%44.92
Sequent Scientific 43.9B154.186.242.84%1.85%62.47

Financial data is updated regularly. All figures are in the company's reporting currency.